Henry A. Fernandez

Insider Reports History

Location
Msci Inc., 88 Pine Street, New York, NY
Signature
/s/ Cecilia Aza, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Henry A. Fernandez:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MSCI Inc. Chairman and CEO, Director Common Stock 1.28M $704M $550.41 Jul 25, 2025 Direct
MSCI Inc. Chairman and CEO, Director Common Stock 507K $283M $557.98 Jul 24, 2025 By Henry Fernandez 2024 MSCI Annuity Trust
MSCI Inc. Chairman and CEO, Director Common Stock 333K $178M $535.11 Jul 24, 2025 By Fernandez 2007 Children's Trust
MSCI Inc. Chairman and CEO, Director Premium option to purchase common stock 44.9K $25.1M $557.98 Jul 24, 2025 Direct
MSCI Inc. Chairman and CEO, Director Option to purchase common stock 29.6K $16.5M $557.98 Jul 24, 2025 Direct
MSCI Inc. Chairman and CEO, Director Common Stock 15.4K $8.59M $557.98 Jul 24, 2025 By Daughter
MSCI Inc. Chairman and CEO, Director Common Stock 15.4K $8.59M $557.98 Jul 24, 2025 By Son
Royalty Pharma plc Director Class A Ordinary Shares 65.3K $2.3M $35.24 Jun 30, 2025 Direct
Royalty Pharma plc Director Class A Ordinary Shares 58.2K $1.93M $33.15 Jun 30, 2025 By Fernandez 2007 Children's Trust

Insider Reports Filed by Henry A. Fernandez

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MSCI MSCI Inc. Jul 24, 2025 5 $6.73M 4 Jul 28, 2025 Chairman and CEO, Director
RPRX Royalty Pharma plc Jun 30, 2025 1 $37.5K 4 Jun 30, 2025 Director
RPRX Royalty Pharma plc May 13, 2025 1 $0 4 May 14, 2025 Director
RPRX Royalty Pharma plc Mar 31, 2025 1 $37.5K 4 Apr 1, 2025 Director
MSCI MSCI Inc. Feb 24, 2025 3 $3.04M 4 Feb 25, 2025 Chairman and CEO, Director
MSCI MSCI Inc. Feb 6, 2025 2 -$19M 4 Feb 10, 2025 Chairman and CEO, Director
MSCI MSCI Inc. Jan 31, 2025 3 $0 4 Feb 4, 2025 Chairman and CEO, Director
MSCI MSCI Inc. Jan 27, 2025 1 $0 4 Jan 29, 2025 Chairman and CEO, Director
RPRX Royalty Pharma plc Dec 31, 2024 1 $37.5K 4 Jan 2, 2025 Director
MSCI MSCI Inc. Dec 5, 2024 3 $1.78M 4 Dec 9, 2024 Chairman and CEO, Director
RPRX Royalty Pharma plc Sep 30, 2024 1 $37.5K 4 Sep 30, 2024 Director
RPRX Royalty Pharma plc Jun 28, 2024 1 $37.5K 4 Jun 28, 2024 Director
RPRX Royalty Pharma plc Jun 7, 2024 1 $0 4 Jun 10, 2024 Director
MSCI MSCI Inc. Apr 25, 2024 15 $6.06M 4 Apr 26, 2024 Chairman and CEO, Director
RPRX Royalty Pharma plc Mar 28, 2024 1 $37.5K 4 Apr 2, 2024 Director
MSCI MSCI Inc. Feb 5, 2024 4 -$29.5M 4 Feb 7, 2024 Chairman and CEO, Director
RPRX Royalty Pharma plc Dec 29, 2023 1 $37.5K 4 Dec 29, 2023 Director
RPRX Royalty Pharma plc Sep 29, 2023 1 $37.5K 4 Oct 3, 2023 Director
RPRX Royalty Pharma plc Jun 30, 2023 1 $37.5K 4 Jun 30, 2023 Director
RPRX Royalty Pharma plc Jun 23, 2023 1 $0 4 Jun 26, 2023 Director
RPRX Royalty Pharma plc Mar 31, 2023 1 $37.5K 4 Mar 31, 2023 Director
MSCI MSCI Inc. Feb 8, 2023 2 -$8.77M 4 Feb 10, 2023 Chairman and CEO, Director
RPRX Royalty Pharma plc Dec 30, 2022 1 $37.5K 4 Jan 3, 2023 Director
RPRX Royalty Pharma plc Sep 30, 2022 1 $37.5K 4 Sep 30, 2022 Director
RPRX Royalty Pharma plc Jun 30, 2022 1 $37.5K 4 Jun 30, 2022 Director
RPRX Royalty Pharma plc Jun 24, 2022 1 $0 4 Jun 24, 2022 Director
RPRX Royalty Pharma plc Mar 31, 2022 1 $37.5K 4 Apr 1, 2022 Director
RPRX Royalty Pharma plc Feb 24, 2022 1 $1.22M 4 Feb 25, 2022 Director
MSCI MSCI Inc. Feb 7, 2022 6 -$23.4M 4 Feb 9, 2022 Chairman and CEO, Director
RPRX Royalty Pharma plc Dec 31, 2021 1 $37.5K 4 Jan 3, 2022 Director
RPRX Royalty Pharma plc Sep 30, 2021 1 $37.5K 4 Sep 30, 2021 Director
RPRX Royalty Pharma plc Jun 30, 2021 1 $37.5K 4 Jun 30, 2021 Director
RPRX Royalty Pharma plc Jun 25, 2021 1 $0 4 Jun 29, 2021 Director